A new company dedicated to the discovery of small-molecule immunomodulators to treat cancer has been launched in the Walloon region of Belgium. The company, iTeos Therapeutics SA, has secured €9 million in Series A funding. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
